Rankings
▼
Calendar
DAWN Q1 2020 Earnings — Day One Biopharmaceuticals, Inc. Revenue & Financial Results | Market Cap Arena
DAWN
Day One Biopharmaceuticals, Inc.
$2B
Q1 2020 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
-$14,000
Operating Income
-$2M
Net Income
-$2M
EPS (Diluted)
$-0.02
Cash Flow
Operating Cash Flow
-$2M
Free Cash Flow
-$2M
Stock-Based Comp.
$59,000
← FY 2020
All Quarters
Q2 2020 →
